Conatus Pharmaceutic (NQ: CNAT )

0.5560 USD UNCHANGED

Last Price Updated: 7:43 PM EDT, May 26, 2020 Add to My Watchlist

Price and Volume

Volume	0
Open	0.5560
Bid (Size)	0.5500 (10)
Ask (Size)	0.5530 (51)
Prev. Close	0.5560
Today's Range	0.5560 - 0.5560
52wk Range	0.3200 - 0.7500
Shares Outstanding	35,683,457
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Histogen Announces Successful Completion of its Merger with Conatus Pharmaceuticals

May 27, 2020

Leading Independent Proxy Advisory Firms Recommend Conatus Pharmaceuticals Shareholders Vote in Favor of its Merger with Histogen and the Required Reverse Stock Split

May 18, 2020

Performance

YTD	N/A	N/A
1 Month	N/A	N/A
3 Month	N/A	N/A
6 Month	N/A	N/A
1 Year	+58.86%	+58.86%

More News

Histogen Publishes Preclinical Data on its HST 004 Spinal Disc Program

May 14, 2020

Histogen Receives US FDA IND Approval to Initiate Phase 1b/2a Trial of HST 001 in Androgenic Alopecia

May 11, 2020

The Conatus Pharmaceuticals Special Meeting of Stockholders Seeking Approval for Proposed Merger with Histogen Inc. will Reconvene on May 21, 2020

May 07, 2020

Conatus Pharmaceuticals Reports First Quarter 2020 Financial Results and Strategic Process Update

May 01, 2020

Histogen Announces Investigational Device Exemption Application for HST 002

April 20, 2020

Histogen Publishes New Preclinical Data on its HST 003 Orthopedic Program

April 15, 2020

Histogen Announces Investigational New Drug Application Amendment for HST 001

April 06, 2020

Conatus Pharmaceuticals Reports 2019 Financial Results and Strategic Process Update

March 11, 2020

Histogen to Present at BIO CEO & Investor Conference

February 06, 2020

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.